• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol. Optimization of Group Size in Pool Testing Strategy for SARS-CoV-2: A Simple Mathematical Model

tetano

Editor, Senior Moderator
J Med Virol. 2020 Apr 24.
doi: 10.1002/jmv.25929. Online ahead of print.
Optimization of Group Size in Pool Testing Strategy for SARS-CoV-2: A Simple Mathematical Model


Diego Arag?n-Caqueo[SUP] 1 [/SUP], Javier Fern?ndez-Salinas[SUP] 1 [/SUP], David Laroze[SUP] 2 [/SUP]



Affiliations

Abstract

COVID-19 has reached unprecedented pandemic levels and is affecting almost every country in the world. Ramping up the testing capacity of a country supposes an essential public health response to this new outbreak. A Pool testing strategy where multiple samples are tested in a single RT-PCR kit could potentially increase a country's testing capacity. The aim of this study is to propose a simple mathematical model to estimate the optimum number of pooled samples according to the relative prevalence of positive tests in a particular healthcare context, assuming that if a group tests negative, no further testing is done whereas if a group tests positive, all the subjects of the group are retested individually. The model predicts group sizes that range from 11 to 3 subjects. For a prevalence of 10% of positive tests, 40.6% of tests can be saved using testing groups of 4 subjects. For a 20% prevalence, 17.9% of tests can be saved using groups of 3 subjects. For higher prevalences, the strategy flattens and loses effectiveness. Pool testing individuals for SARS-CoV-2 is a valuable strategy that could considerably boost a country's testing capacity. However, further studies are needed to address how large these groups can be, without losing sensitivity on the RT-PCR. The strategy best works in settings with a low prevalence of positive tests. It is best implemented in subgroups with low clinical suspicion. The model can be adapted to specific prevalences, generating a tailored to the context implementation of the pool testing strategy. This article is protected by copyright. All rights reserved.
 
Back
Top Bottom